0 CHECKOUT

PRODUCT FILTERS

REGION

6
2
2
2
1

COUNTRY

2
1

PRICE

0
1
1
11

PUBLISHED

0
4
5
11

PRODUCT TYPE

11

Brain Cancer

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

11 Products

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain tumor in adults. The current treatment modalities available in the market are surgical resection followed by chemotherapy...

Published:  June 2015
Price:  From

Brain Cancer Treatment Drugs Markets in China

China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...

Published:  July 2015
Price:  From

Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the glioblastoma multiforme (brain cancer) market not available elsewhere. This reports...

Published:  January 2014
Price:  From

Brain Cancer Pipeline Highlights - 2015

The latest report Brain Cancer Pipeline Highlights – 2015 Update, provides most up-to-date information on key pipeline molecules in the global Brain Cancer market. It covers emerging therapies for Brain...

Published:  July 2015
Price:  From

Brain Cancer Drug Pipeline Update 2015

Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases...

Published:  June 2015
Price:  From

Brain Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 245 targeted molecular therapies known to affect more than 239 specific intracellular signaling pathways...

Published:  January 2015
Price:  From

2011 O.U.S. Markets For External Radiation Therapy

2011 O U S Markets For External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

Published:  May 2011
Price:  From

2011 Global Markets for External Radiation Therapy

2011 Global Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

Published:  May 2011
Price:  From

2011 U.S. Markets for External Radiation Therapy

2011 U S Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data -...

Published:  May 2011
Price:  From

Global Neurosurgical Product Markets

Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors Intracranial shunts are...

Published:  March 2009
Price:  From

European Head and Neck Cancer Therapeutics Markets

This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market In this research, Frost & Sullivan's...

Published:  August 2007
Price:  From
Loading Indicator

Our Clients